PR-39

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NamePR-39
Drug Alias NamePR-26
ClassificationSmall molecules > Synthetic peptideSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionCell wall inhibitors
TargetsUpdating
Therapy Area/IndicationsMycobacterium InfectionsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSweden
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companies +[1]  N/A
Active IndicationsN/A
Inactive IndicationsMycobacterium InfectionsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A